Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Union Investment

Tracked across 4 events · 291 articles · First seen Jun 25, 2026 · Last active Sep 11, 2026

Sentiment
10
Attention
7
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 40
Business
Impact: Asset manager; notes comfort if Novo leaves profit warning era.
Aug 03, 2026 · 6 articles
6 0
Business
Novartis announced on September 8, 2026 that its Phase III HARBOR study of del-desiran, an antibody oligonucleotide conjugate for myotonic dystrophy type 1 (DM1), failed to show statistically significant improvement versus placebo on the primary…
Impact: Union Investment portfolio manager Markus Manns said the two trial failures were unfortunate but within normal drug development probabilities, while noting the M&A strategy needs improvement.
Sep 08, 2026 · 21 articles
7 0
Regulatory
Impact: Investment firm; its fund manager Markus Manns called the ruling a milestone for Bayer.
Jun 25, 2026 · 133 articles
6 0
Business
Impact: Union Investment's ESG analyst expressed concerns about Shein's sustainability.
Jul 26, 2026 · 131 articles
ERGEN INTELLIGENCE
Track Union Investment live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.